- 全部删除
- 您的购物车当前为空
CYP1B1-IN-7 是一种具有选择性和高效性的 CYP1B1 抑制剂,在多西他赛耐药 CYP1B1 过表达的 MCF-7 细胞系中显示出细胞毒性作用,可用于和抗癌化合物协同治疗癌症。
为众多的药物研发团队赋能,
让新药发现更简单!
CYP1B1-IN-7 是一种具有选择性和高效性的 CYP1B1 抑制剂,在多西他赛耐药 CYP1B1 过表达的 MCF-7 细胞系中显示出细胞毒性作用,可用于和抗癌化合物协同治疗癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 266 | In stock | |
5 mg | ¥ 619 | In stock | |
10 mg | ¥ 993 | In stock | |
25 mg | ¥ 1,670 | In stock | |
50 mg | ¥ 2,480 | In stock | |
100 mg | ¥ 3,660 | In stock | |
200 mg | ¥ 5,220 | In stock |
CYP1B1-IN-7 相关产品
产品描述 | CYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds. |
靶点活性 | CYP1B1:75 nM |
分子量 | 292.76 |
分子式 | C19H13ClO |
CAS No. | 52601-58-8 |
Smiles | O=C(C=CC1=CC=C(Cl)C=C1)C=2C=CC=3C=CC=CC3C2 |
密度 | 1.241 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 15 mg/mL (51.24 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容